Related Experiment Video
Updated: Mar 7, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.4K
Development of a functional sarcopenia model utilizing a microcantilever microphysiological system as a phenotypic
Himanshi Jangir1, Leandro H Gallo1, Russell Emmons2
1Nanoscience Technology Center, University of Central Florida, 12424 Research Pkwy, Suite 401, Orlando, FL 32826 USA.
In Vitro Models
|March 6, 2026
Summary
Researchers developed a novel in vitro model for sarcopenia, a muscle-wasting condition. This functional model accurately simulates disease progression and can be used to test new therapeutic strategies.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Muscle Physiology
Background:
- Sarcopenia is characterized by skeletal muscle mass and function decline, often co-occurring with inflammatory diseases.
- Understanding sarcopenia's mechanisms requires advanced in vitro models that mimic disease progression.
Purpose of the Study:
- To develop and validate a novel in vitro functional model for studying sarcopenia.
- To assess the long-term effects of TNF-alpha induced inflammation on skeletal muscle cells.
Main Methods:
- Human induced pluripotent stem cell-derived skeletal muscle cells were cultured and treated with TNF-alpha.
- Muscle function was assessed using microcantilever measurements of contraction amplitude, force, and fatigue.
- Myotube width and reactive oxygen species production were monitored over 32 days.
Main Results:
- The model demonstrated sustained reduction in myotube width and impaired muscle function for up to 32 days post-treatment.
- Increased reactive oxygen species production indicated disease progression and tissue degradation.
- The model successfully recapitulated key physiological signatures of sarcopenia.
Conclusions:
- This study presents the first microphysiological system for sarcopenia evaluation on a microcantilever platform.
- This model can be utilized for therapeutic screening and integrated into multi-organ systems to study inflammatory comorbidities.

